As of April 20, 2025, Guardant Health (GH) has a market cap of $5.55 billion USD. According to our data, Guardant Health is ranked No.2410 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 20, 2025 | $5.55 B |
47.04%
|
Dec 31, 2024 | $3.77 B |
12.94%
|
Dec 29, 2023 | $3.34 B |
-0.55%
|
Dec 30, 2022 | $3.36 B |
-72.81%
|
Dec 31, 2021 | $12.36 B |
-22.39%
|
Dec 31, 2020 | $15.92 B |
64.93%
|
Dec 31, 2019 | $9.65 B |
107.87%
|
Dec 31, 2018 | $4.64 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Illumina
ILMN
|
$11.27 B |
-0.000 M
|
![]() USA
|
![]() Exact Sciences
EXAS
|
$7.72 B |
-0.000 M
|
![]() USA
|
![]() Natera
NTRA
|
$20.02 B |
0.001 M
|
![]() USA
|
![]() Myriad Genetics
MYGN
|
$0.70 B |
0.000 M
|
![]() USA
|
![]() NeoGenomics
NEO
|
$1.23 B |
0.000 M
|
![]() USA
|
![]() Adaptive Biotechnologies
ADPT
|
$1.09 B |
0.000 M
|
![]() USA
|
![]() Personalis
PSNL
|
$0.28 B |
0.000 M
|
![]() USA
|
![]() Fulgent Genetics
FLGT
|
$0.55 B |
0.000 M
|
![]() USA
|
![]() Guardant Health
GH
|
$5.55 B |
-0.000 M
|
![]() USA
|
![]() Pacific Biosciences
PACB
|
$0.35 B |
-0.000 M
|
![]() USA
|
![]() 10x Genomics
TXG
|
$0.92 B |
0.103 B
|
![]() USA
|
![]() Quanterix
QTRX
|
$0.20 B |
0.000 M
|
![]() USA
|
Market Cap | = | GH Stock Price | * | GH Shares Outstanding |
= | $44.97 | * | 0.12 B | |
= | $5.55 B |